by Tiana Tonrey | Jan 23, 2020 | Press Release, Press Releases, Technical Content
Golden, Colorado—January 23, 2020—Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced its CEO letter to its shareholders including discussion of its 2019 results of operations ended October 31st 2019 and its expansion plans for 2020. Dear...
by Tiana Tonrey | Jan 22, 2020 | Press Release, Press Releases
Golden, Colorado – January 22, 2020-Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma announced a private placement of Units consisting of Series A Convertible Preferred Stock (“Series A Preferred”), Class A Warrants and Class B Warrants. . The Company has...
by Tiana Tonrey | Jan 22, 2020 | Press Release, Press Releases
GOLDEN, CO / ACCESSWIRE / November 5, 2019 / Vitro Diagnostics, Inc. (OTCPK:VODG), dba Vitro Biopharma announced the appointment of Dr. In Sok Yi MD to its Scientific Advisory Board (SAB). Dr Yi is board certified in Orthopedic Surgery and Surgery of the Hand. He...
by Tiana Tonrey | Oct 2, 2019 | Press Release, Press Releases
Vitro Biopharma 3rd Quarter ended July 31st 2019 Financial Results of Operations Golden, Colorado-September 25th, 2019-Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced its 3rd quarter ended September 24th 2019 financial results of operations....
by Tiana Tonrey | Jun 18, 2019 | Press Release, Press Releases
Vitro Biopharma 2nd Quarter ended April 30th 2019 Financial Results of Operations Golden, Colorado-June 19th, 2019-Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced its 2nd quarter ended April 30th 2019 financial results of operations. Vitro...
by Tiana Tonrey | Apr 30, 2019 | Press Release, Press Releases
Golden, Colorado-April 30, 2019-Vitro Diagnostics, Inc. (OTCPK: VODG), dba Vitro Biopharma one of the world’s emerging biotechnology companies focused on allogeneic Mesenchymal Stem Cell (“MSC”) research and clinical products including AlloRx Stem Cells™, Brain Grow...
